Search

Your search keyword '"van der Schoot, C Ellen"' showing total 961 results

Search Constraints

Start Over You searched for: Author "van der Schoot, C Ellen" Remove constraint Author: "van der Schoot, C Ellen"
961 results on '"van der Schoot, C Ellen"'

Search Results

2. Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation study

3. Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus

4. Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial

5. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

9. Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial

10. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

12. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study

13. Immunoassay for quantification of antigen-specific IgG fucosylation

14. Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.

16. Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma

18. Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection.

19. Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching.

21. Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation

22. Development and validation of a universal blood donor genotyping platform: a multinational prospective study

25. Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands

26. Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients

27. Assessment of IgG-Fc glycosylation from individual RhD-specific B cell clones reveals regulation at clonal rather than clonotypic level

28. Extensive red blood cell matching considering patient alloimmunization risk

29. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

30. Assessment of IgG-Fc glycosylation from individual RhD-specific B cell clones reveals regulation at clonal rather than clonotypic level

31. Extensive red blood cell matching considering patient alloimmunization risk

32. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

33. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

36. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

37. Monoclonal RhD prophylaxis: high time to evaluate efficacy

40. Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination

41. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.

44. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

47. Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia

48. Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors

Catalog

Books, media, physical & digital resources